STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Clearwater Analytics Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 filed for Clearwater Analytics Holdings, Inc. (CWAN) reports a proposed sale of 10,000 common shares through Morgan Stanley Smith Barney, valued at $207,700, with an approximate sale date of 09/08/2025 on the NYSE. The filing shows the shares were acquired as Restricted Stock Units on 02/28/2024 and paid on that date. It also discloses two recent sales by the same person: a 10,000‑share 10b5‑1 sale on 08/20/2025 for $200,000 and a 5,273‑share sale on 06/30/2025 for $114,282.78. The filer affirms no undisclosed material adverse information and references Rule 10b5‑1 where applicable.

Positive
  • Disclosure compliance: The filer provides broker, acquisition method, dates, and values, meeting Rule 144 reporting requirements
  • Use of 10b5‑1: Prior 10b5‑1 sale is documented, indicating pre‑planned trading activity
Negative
  • Insider sale disclosed: Proposed sale of 10,000 shares and recent sales (10,000 and 5,273 shares) may be viewed unfavorably by some investors despite being immaterial in size

Insights

TL;DR: Insiders disclosed routine sales totaling small fractions of outstanding shares; this is compliance reporting rather than a material corporate event.

The filing documents a proposed sale of 10,000 common shares valued at $207,700 and notes two recent disposals in June and August 2025. Compared with the issuer's reported outstanding shares (287,938,740), these transactions represent an immaterial ownership change by percentage terms. The sale origin—RSUs granted 02/28/2024—suggests this is disciplined monetization of equity awards rather than a financing or change in control. Investors should view this as standard insider liquidity activity disclosed under Rule 144 and 10b5‑1 procedures.

TL;DR: The form reflects standard insider compliance with Rule 144/10b5‑1; timing and prior 10b5‑1 sale are documented and appropriate.

The notice identifies the broker, planned sale date, acquisition via RSUs, and prior 10b5‑1 sales, which aligns with good disclosure practice. The filer certifies absence of undisclosed material adverse information and notes plan adoption/instruction fields, preserving the safe harbor. Given the quantities and the RSU origin, this filing signals routine governance and insider liquidity rather than governance red flags. Materiality to shareholders is limited based on absolute and relative sizes disclosed.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares is the CWAN Form 144 proposing to sell?

The filing proposes to sell 10,000 common shares through Morgan Stanley Smith Barney, valued at $207,700.

When were the shares to be sold acquired?

The shares were acquired as Restricted Stock Units on 02/28/2024 with payment recorded on the same date.

Were there any recent sales by the same person recorded in the filing?

Yes. The filing discloses a 10b5‑1 sale of 10,000 shares on 08/20/2025 for $200,000 and a sale of 5,273 shares on 06/30/2025 for $114,282.78.

On which exchange is the proposed sale expected to occur?

The proposed sale lists the NYSE as the securities exchange.

How material is this sale relative to outstanding shares?

The filing lists 287,938,740 shares outstanding; the proposed 10,000‑share sale is immaterial as a percentage of outstanding shares.
Clearwater Analytics Hldgs Inc

NYSE:CWAN

CWAN Rankings

CWAN Latest News

CWAN Latest SEC Filings

CWAN Stock Data

6.07B
276.65M
0.85%
99.8%
4.74%
Software - Application
Services-prepackaged Software
Link
United States
BOISE